Literature DB >> 27867644

Contemporary drug-eluting stents and companion polymers: durable is not synonymous with harm.

Salvatore Cassese1, Sebastian Kufner1, Adnan Kastrati2.   

Abstract

Year:  2016        PMID： 27867644      PMCID： PMC5107557          DOI： 10.21037/jtd.2016.10.70

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  14 in total

1.  No country for old stents? Improving long-term patient outcomes with biodegradable polymer drug-eluting stents.

Authors:  Robert A Byrne; Adnan Kastrati
Journal:  Expert Rev Cardiovasc Ther       Date:  2012-04

2.  Have we been misled by the ESC DES firestorm?

Authors:  Stéphane Cook; Bernhard Meier
Journal:  EuroIntervention       Date:  2008-03       Impact factor: 6.534

3.  Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.

Authors:  Michael Joner; Aloke V Finn; Andrew Farb; Erik K Mont; Frank D Kolodgie; Elena Ladich; Robert Kutys; Kristi Skorija; Herman K Gold; Renu Virmani
Journal:  J Am Coll Cardiol       Date:  2006-05-05       Impact factor: 24.094

4.  Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials.

Authors:  Giulio G Stefanini; Robert A Byrne; Patrick W Serruys; Antoinette de Waha; Bernhard Meier; Steffen Massberg; Peter Jüni; Albert Schömig; Stephan Windecker; Adnan Kastrati
Journal:  Eur Heart J       Date:  2012-03-24       Impact factor: 29.983

5.  Randomized Comparison of a Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent With a Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention: The SORT OUT VII Trial.

Authors:  Lisette Okkels Jensen; Per Thayssen; Michael Maeng; Jan Ravkilde; Lars Romer Krusell; Bent Raungaard; Anders Junker; Christian Juhl Terkelsen; Karsten Tange Veien; Anton Boel Villadsen; Anne Kaltoft; Hans-Henrik Tilsted; Knud Nørregaard Hansen; Jens Aaroe; Steen Dalby Kristensen; Henrik Steen Hansen; Svend Eggert Jensen; Morten Madsen; Hans Erik Bøtker; Klára Berencsi; Jens Flensted Lassen; Evald Høj Christiansen
Journal:  Circ Cardiovasc Interv       Date:  2016-07       Impact factor: 6.546

6.  Bioresorbable Vascular Scaffolds for Coronary Revascularization.

Authors:  Dean J Kereiakes; Yoshinobu Onuma; Patrick W Serruys; Gregg W Stone
Journal:  Circulation       Date:  2016-07-12       Impact factor: 29.690

7.  Bioresorbable Vascular Scaffold Technology Benefits From Healthy Skepticism.

Authors:  Salvatore Cassese; Adnan Kastrati
Journal:  J Am Coll Cardiol       Date:  2016-03-01       Impact factor: 24.094

Review 8.  Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials.

Authors:  Salvatore Cassese; Robert A Byrne; Gjin Ndrepepa; Sebastian Kufner; Jens Wiebe; Janika Repp; Heribert Schunkert; Massimiliano Fusaro; Takeshi Kimura; Adnan Kastrati
Journal:  Lancet       Date:  2015-11-17       Impact factor: 79.321

Review 9.  Stent Thrombosis With Drug-Eluting Stents and Bioresorbable Scaffolds: Evidence From a Network Meta-Analysis of 147 Trials.

Authors:  Si-Hyuck Kang; In-Ho Chae; Jin-Joo Park; Hak Seung Lee; Do-Yoon Kang; Seung-Sik Hwang; Tae-Jin Youn; Hyo-Soo Kim
Journal:  JACC Cardiovasc Interv       Date:  2016-06-01       Impact factor: 11.195

Review 10.  Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014.

Authors:  Robert A Byrne; Michael Joner; Adnan Kastrati
Journal:  Eur Heart J       Date:  2015-09-28       Impact factor: 29.983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.